Using clopidogrel in acute coronary syndromes without ST-segment elevation

Gregory P. Gerschutz, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Deepak L. Bhatt, MD
Program Director, Interventional Cardiology Fellowship, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail [email protected]

Dr. Bhatt has indicated that he has received grant or research support from the Bristol-Myers Squibb and Sanofi-Synthelabo corporations.

Gregory P. Gerschutz, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Deepak L. Bhatt, MD
Program Director, Interventional Cardiology Fellowship, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail [email protected]

Dr. Bhatt has indicated that he has received grant or research support from the Bristol-Myers Squibb and Sanofi-Synthelabo corporations.

Gregory P. Gerschutz, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Deepak L. Bhatt, MD
Program Director, Interventional Cardiology Fellowship, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail [email protected]

Dr. Bhatt has indicated that he has received grant or research support from the Bristol-Myers Squibb and Sanofi-Synthelabo corporations.